← Back to Search

PlanYourLifespan.org for Cognitive Impairment

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline decision-making at 36 months. will also be measured every six months, up to 42 months.
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how different age-related changes influence a person's ability to make decisions about their long-term care, as well as how social and environmental factors play a role.

Who is the study for?
This trial is for older adults who are part of the LitCog Trial, speak English, live in their own home, and use a computer or tablet with internet. It's not open to those who were in the Advanced Planning for Home Services study.
What is being tested?
The study examines how an online tool called PlanYourLifespan.org affects decision-making regarding living arrangements and long-term care plans among seniors with cognitive challenges like Alzheimer's.
What are the potential side effects?
Since this trial involves using an online planning tool rather than medication, there are no direct medical side effects. However, participants may experience stress or anxiety while making decisions about aging-in-place.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline decision-making at 36 months. will also be measured every six months, up to 42 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline decision-making at 36 months. will also be measured every six months, up to 42 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in long-term care plan decision-making
Secondary study objectives
Number of participants that implement any of their long-term care plans
Participant long-term care goal concordance
Participant utilization of long-term care services

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Access to Web-Based InterventionExperimental Treatment1 Intervention
All study participants will be given access to the web-based study intervention, PlanYourLifespan.org.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,804 Previous Clinical Trials
28,194,606 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,652 Previous Clinical Trials
961,222 Total Patients Enrolled

Media Library

PlanYourLifespan.org Clinical Trial Eligibility Overview. Trial Name: NCT03960476 — N/A
Mild Cognitive Impairment Research Study Groups: Access to Web-Based Intervention
Mild Cognitive Impairment Clinical Trial 2023: PlanYourLifespan.org Highlights & Side Effects. Trial Name: NCT03960476 — N/A
PlanYourLifespan.org 2023 Treatment Timeline for Medical Study. Trial Name: NCT03960476 — N/A
~50 spots leftby Dec 2025